FDA NDC Directory · JSON-LD · Markdown

Deferasirox

NDC 69539-021 · HUMAN PRESCRIPTION DRUG · TABLET, FOR SUSPENSION

Labeler / ManufacturerMSN LABORATORIES PRIVATE LIMITED
Marketing categoryAbbreviated NDA (generic) · App ANDA209878
Dosage form / routeTABLET, FOR SUSPENSION · ORAL
Active ingredientsDEFERASIROX (125 mg/1)
Marketing started20191120
Package count4

External sources

Source: openFDA. Public-domain (CC0).